Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Clin Transl Oncol. 2009 Jul;11(7):486-7. doi: 10.1007/s12094-009-0390-2.

Abstract

Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / etiology
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Drug Eruptions / pathology*
  • Female
  • Humans
  • Intertrigo / chemically induced*
  • Intertrigo / pathology*
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / adverse effects*

Substances

  • Antibiotics, Antineoplastic
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin